F-group (family)
5.1.3.134 BNR, BNR_2
Ligands and drugs
117
Member domains
101
with ligand contacts (≤ 4 Å)
86.3% of members
97
with DrugDomain annotations
82.9% of members
88
with a DrugBank compound
75.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5.1.3.134 belongs to X-group 5 beta-propeller-like, which binds 7.8 ligand superclasses per 20 proteins, broader than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03991 | DAN | 2-deoxy-2,3-dehydro-N-acetylneuraminic acid | 23 |
| DB02600 | G39 | Oseltamivir acid | 7 |
| DB00558 | ZMR | Zanamivir | 5 |
| DB03721 | SIA | N-acetyl-alpha-neuraminic acid | 4 |
| DB03309 | NHE | N-cyclohexyltaurine | 2 |
| DB04211 | FSI | 5-(acetylamino)-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid | 2 |
| DB01956 | TAU | Taurine | 1 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 1 |
| DB04265 | SLB | N-acetyl-beta-neuraminic acid | 1 |
| DB06527 | A20 | Tramiprosate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| DAN | 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID | 23 |
| CL | CHLORIDE ION | 19 |
| OPX | (1s,3R,4S)-1-[(cyclohexylamino)methyl]-3,4-dihydroxycyclopentanesulfonic acid | 8 |
| CAmetal | CALCIUM ION | 7 |
| G39 | (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid | 7 |
| ZMR | ZANAMIVIR | 5 |
| SIA | N-acetyl-alpha-neuraminic acid | 4 |
| 6UD | 5-acetamido-2,6-anhydro-3,5,9-trideoxy-9-triazan-1-yl-D-glycero-D-galacto-non-2-enonic acid | 2 |
| FSI | 5-acetamido-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid | 2 |
| JKK | 2-[(3-chlorobenzyl)amino]ethanesulfonic acid | 2 |
| NHE | 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID | 2 |
| R7H | (4~{S},5~{R},6~{R})-5-acetamido-6-[(1~{R},2~{S})-3-[[1-(2-ethoxyethyl)-1,2,3-triazol-4-yl]methylsulfanyl]-1,2-bis(oxidanyl)propyl]-4-oxidanyl-oxane-2-carboxylic acid | 2 |
| 0H9 | 2-[(4-methoxybenzyl)amino]ethanesulfonic acid | 1 |
| 0V7 | 2-[(3-fluorobenzyl)amino]ethanesulfonic acid | 1 |
| 0V8 | 2-[(3-bromobenzyl)amino]ethanesulfonic acid | 1 |
| 17Y | (1R,2S)-cyclopentane-1,2-diol | 1 |
| 19D | (1R,2R,3R,4R,5R,7R)-2-(acetylamino)-7-[(1R)-1,2-dihydroxyethyl]-4-fluoro-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid | 1 |
| 43Z | Optactamide | 1 |
| 7HV | 2-[(3,4-dichlorobenzyl)amino]ethanesulfonic acid | 1 |
| A20 | 3-aminopropane-1-sulfonic acid | 1 |